Earnings Preview — 5164 total
ATKR reports quarterly results today, but the earnings print is almost beside the point — Prysmian S.p.A. announced a definitive agreement to acquire the company for $3.3 billion on August 3, and that deal now…
BSM heads into its Q2 2026 print with a clear insider conviction signal stacked against a market that has only recently started to agree. The most striking data point ahead of today's release is the cluster of insider…
SHAK heads into its August 5 earnings print with the most interesting story sitting not in the short book, but in the divergence between what insiders did in May and what analysts have been doing ever since. The…
Lantheus Holdings enters its August 6 earnings report with analyst sentiment shifting decisively negative in the final days before the release — a meaningful change from the broadly constructive tone that prevailed…
MTUS heads into its August 4 earnings release with options traders noticeably more defensive than they have been all year. The shift in options positioning is the sharpest signal in the data. The put/call ratio has…
IVT heads into its August 4 earnings report with options positioning sending an unusually sharp defensive signal — one that sits well outside the norm for this quiet retail REIT. The clearest anomaly is in the options…
Veracyte arrives at today's after-hours print having shed more than 21% in the past month, with the stock closing Monday at $44.85 — and the week's damage of nearly 20% coming on top of an additional 3% drop in the…
Applied Optoelectronics heads into its August 6 earnings print having staged a sharp rebound, with shorts quietly unwinding and analysts still pricing in significant upside — despite the stock trading well below its…
AHRT reports today as a REIT in active transformation, with positioning data that tells a story of measured caution rather than aggressive short pressure. The lending market is the least contested angle heading into…
Boise Cascade walks into today's Q2 earnings release in a dramatically different position than the one described four days ago: the stock has surged 8.7% in a single session to $83.03, erasing the bearish price…
Diamondback Energy reports Q2 2026 results today against a backdrop of broadly positive but quietly recalibrating analyst sentiment. Options positioning has grown more defensive ahead of the print. The put/call ratio…
NMFC heads into its Q2 earnings print today having already shown its hand — and the market liked what it saw. The most striking element of this setup is the pre-market reaction. Q2 net investment income of $0.47 per…
Independence Realty Trust heads into its Q2 earnings release with the most consequential analyst action in months pointing in the bulls' direction — but the stock still trades well below where the Street thinks it…
Sabra Health Care REIT reports today with a clear tension at its core: short sellers have been quietly exiting even as the stock has slid sharply in the past week, creating a divergence that makes the positioning…
Golub Capital BDC reports today with its borrow market notably tighter than usual — yet short sellers have been quietly retreating over the past month, setting up a split picture heading into the print. Availability in…
Fortinet heads into its August 6 results carrying an unusual wrinkle: the stock already reported on July 29, rallied sharply, and now must answer for a price that has run well past where the analyst community is…
Addus HomeCare heads into today's earnings print with the most extreme options defensive posture it has seen in the past year. The options signal dominates the setup. The put/call ratio hit 4.36 on Monday — three…
JBT Marel Corporation reports Q2 results today with options traders sending an unusually bullish signal — one that sits in sharp contrast to the short-selling pressure that has built quietly over the past month. The…
MercadoLibre heads into Wednesday's Q2 print with a stock riding a one-month rally but analysts still divided on whether the margin story has turned a corner. The broader positioning picture here is notably calm for a…
Jazz Pharmaceuticals reports Q2 earnings on August 5 against a backdrop of unusually broad analyst conviction — and options markets that have quietly grown more cautious in recent weeks. The clearest pre-earnings…
